3D Glass Solutions Inc | Date: 2016-09-26
The present invention includes compositions and methods of creating electrical isolation and ground plane structures, around electronic devices (inductors, antenna, resistors, capacitors, transmission lines and transformers) in photo definable glass ceramic substrates in order to prevent parasitic electronic signals, RF signals, differential voltage build up and floating grounds from disrupting and degrading the performance of isolated electronic devices by the fabrication of electrical isolation and ground plane structures on a photo-definable glass substrate.
Flemming J.H.,3D Glass Solutions Inc. |
Cook R.,3D Glass Solutions Inc. |
Sibbet S.,3D Glass Solutions Inc. |
Schmidt C.F.,3D Glass Solutions Inc. |
And 2 more authors.
Microwave Journal | Year: 2014
The new APEX® Glass process involves the development of a new photo-definable glass ceramic material, which is processed in a three-step batch process enabling an high volume manufacturing (HVM) solution/or glass microfabrication. The material's fine surface finish also enables an MCM capability with fully integrated thin film passive components, such as resistors, capacitors, and inductors. The APEX® Glass process features TGVs, trenches, and embedded microstructures, which can be simultaneously microfabricated using a precise, rapid and cost effective batch manufacturing process. The ability to produce electronic packages that integrate these types of structures enables many types of packaging architectures across military communications and portable consumer electronics industries. APEX Glass is a photosensitive glass-ceramic material capable of existing in both an amorphous glass state and a ciystallized ceramic state.
3D Glass Solutions Inc | Date: 2015-01-23
A method of fabrication and device made by preparing a photosensitive glass substrate comprising at least silica, lithium oxide, aluminum oxide, and cerium oxide, masking a design layout comprising form one or more micro lens on the photosensitive glass substrate, exposing at least one portion of the photosensitive glass substrate to an activating energy source, exposing the photosensitive glass substrate to a heating phase of at least ten minutes above its glass transition temperature, cooling the photo sensitive glass substrate to transform at least part of the exposed glass to a crystalline material to form a glass-crystalline substrate and etching the glass-crystalline substrate with an etchant solution to form one or more a micro lens.
Agency: NSF | Branch: Standard Grant | Program: | Phase: | Award Amount: 168.92K | Year: 2010
This Small Business Innovation Research (SBIR) Phase I project addresses the need for a single silica-based multiplexed microsphere that is not available on the market today because solid silica microspheres must be baked at elevated temperatures (<300C), destroying the internal organic dyes. While polystyrene microspheres are the most prevalent microsphere used in bio-assays, silica microspheres are desirable for a wide variety of reasons and the glass matrix itself offers significant advantages relative to polymer-based materials. The overall research objective is to develop a low-temperature sol-gel manufacturing process that will produce a more uniform Multiplexed Bead Array Assay (MBAA) product characterized by greater chemistry consistency as compared to existing product available today. With overall success, this program will create the ability to produce a single parent microsphere capable of being transformed into at least 10 daughter microspheres, each with a unique and distinguishable autofluorescence characteristic. This transition to a novel manufacturing process for silica-based microspheres will solve many of the problems encountered with high-temperature microsphere manufacturing, while decreasing the cost limitations associated with today?s multiplexed microspheres.
The broader impact/commercial potential of this project is to target the technical limitations and cost constraints of multiplexed microsphere assays to deliver more data with less time and effort than other bioassay products. Current approaches to manufacturing these microspheres are very cumbersome, inefficient, and require literally hundreds of manufacturing steps and each requiring quality control to ensure overall product reliability. These combined manufacturing steps make these products very expensive. Therefore, a more streamlined approach to producing multiplexed microspheres would translate into significantly decreased production costs, which would ultimately make these microspheres more affordable to researchers and clinicians. This would allow for the expanded use of multiplexing assays by clinicians and researchers and accelerate the discovery process, especially in the proteomic and genomic fields. Additionally, this technology is expected to increase innovative medical research, reduce diagnostic costs and expedite promising areas of exploration. If successful, this platform would spur competition, create new jobs and provide significant trade and export opportunities.